Speculating in Takeover Targets Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets

ULBI 6.750

-1.7%

Nov 7 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: richardred	1/28/2005 1:16:42 PM
	Read Replies (5) of 7243

My focus is still on generics and so is Merck of Germany. merck.de Germany's Merck KGAA (DE:659990: news, chart, profile) fell 0.3 percent after it said it's agreed to sell its electronic chemicals unit to BASF. About Merck Generics Founded in 1984 and a member of the Merck Group since 1994, the Merck Generics Group is one of the fastest-growing generics businesses in the world. With global sales approaching USD 2 billion in 2004, Merck Generics ranks among the top five companies worldwide in this highly competitive market. Generics sales increased from roughly EUR 100 million in 1995 to EUR 1,5 billion in 2003, mainly through strong organic growth and supported by acquisitions. The business focuses on the development, manufacture and sale of generic and specialized pharmaceuticals and holds leading positions in major markets. With a broad portfolio of products covering nearly all the important therapeutic areas, Merck Generics is represented in more than 90 countries world-wide.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next